After completing its testing of LabgnosticPT, PathGroup began using the interface last fall to send the College Surveys for quantitative assays. “Back in November, I was able to order seven Surveys in 25 minutes through Labgnostic,” Miller explains. “Those same Surveys would have taken at least an hour to order and distribute manually.” With some PathGroup facilities processing more than 190 Surveys a year, she adds, the reduction in administrative time allows staff to redirect effort toward patient‑focused work.
As Labgnostic continues to work with PathGroup, it is expanding its footprint in the United States via other products. The company is offering LabReach, a portal through which pathology laboratories can extend electronic test ordering and results reporting to customers “that sit outside of mainstream health care organizations,” such as prisons, hospices, and fertility clinics. It is also deploying Labgnostic Scope, a module for the more complex workflows in genetic testing and case-driven anatomic pathology submissions.
—Nicola Parry
XiFin offering AI capabilities for RCM workflows
XiFin has introduced XiFin Empower AI, a revenue cycle management ecosystem for coordinating artificial intelligence, automation, and agentic workflows across health care revenue operations.
The solution, built on XiFin’s encounter, financial, and payer data, features a suite of applied and agentic AI capabilities spanning correspondence, documentation handling, patient out-of-pocket estimates, payer response interpretation, complex denial prioritization, and patient-specific and payer-aligned appeal package creation.
Among the modules in the RCM offering is XiFin Empower AI Appeals Agent, which reviews claim and denial data alongside supporting clinical documentation; retrieves relevant medical necessity and policy documentation; creates patient-specific appeal letters and evidence packets; and assembles complete appeal packages and submits them through payer portals, eFax, or mail services.
The solution also provides XiFin Empower AI DocExtract, which eliminates the handling of manual correspondence across the revenue cycle. The capability parses, orients, extracts, separates, classifies, and labels documents and routes them seamlessly into the XiFin Empower DocStore document-management module.
Another module, XiFin Empower AI Insurance Snap and Map, automatically extracts and validates insurance information from submitted card images or subscriber identification using optical character-recognition technology, machine learning, and payer mapping logic.
XiFin, 866-934-6364
Diagnostic Medicine Consortium demonstrates tools at workshop
The Diagnostic Medicine Consortium, a joint venture nonprofit initiative of the Project Santa Fe Foundation and Association for Pathology Informatics, unveiled its ZetaStorm neurosymbolic artificial intelligence system and demonstrated its Journeys visualization dashboard at last month’s Project Santa Fe Clinical Lab 2.0 workshop.
The ZetaStorm system can build and verify auditable, secure software in real time from verbal descriptions. “During the [workshop] demonstration, ZetaStorm generated a clinical trial design tool that extends beyond traditional eligibility criteria to forecast potential clinical trial outcomes—built live in front of the audience,” according to a press release from the consortium.
The targeted clinical trial infrastructure draws on biomarker signatures derived from large real-world data sets, so the platform allows on-demand biomarker validation within the framework. The system “creates a critical bridge between the in vitro diagnostics industry and pharmaceutical research, aligning diagnostic capabilities with the emerging demands of targeted clinical trials,” reported DMC chief technology officer Vincent Laufer, MD, PhD, in the press release.